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Abstract
Background: Objective: To evaluate the usefulness of a clinical scorecard in managing sore throat in general
practice.
Design: Validation study of scorecard for sore throat with a throat swab culture used as the ‘gold standard’.
Setting: A solo family practice in rural New South Wales, Australia
Participants: Patients attending with sore throat.
Methods: Patients from the age of 5 years and above presenting with the main symptom of a sore throat, and
who have not had any antibiotic treatment in the previous two weeks, were invited to participate in the study.
The doctor completed a scorecard for each patient participating and took a throat swab for culture. Adult patients
(> 16 yrs) were asked to complete a patient satisfaction questionnaire, while guardians accompanying children
(5 yr to < 16 yrs old) were asked to complete a similar, guardian questionnaire.
Main outcome measures:
1. Ability of a new scorecard to differentiate between bacterial and non-bacterial sore throat.
2. Patients’ trust in the scorecard.
Results: The scorecard has a sensitivity of 93.33%, a specificity of 63.16%, a positive predictive value of 50% and a
negative predictive value of 96%. The sensitivity is better than other sore throat scorecards that have been
published but with a slightly lower specificity.
There was a high level of patient trust in the scorecard was (85.8% agreement). Patients also trusted their doctor’s
judgement based on the scorecard (90.6% agreement).
Conclusions: As the scorecard has a high sensitivity but only a moderate specificity, this means that it is more
reliable for negative results, i.e. when the result suggests a viral infection. When the result favours a bacterial sore
throat, then a high sensitivity can mean that there are a number of false positives. GPs can be confident in
withholding antibiotics when the scorecard indicates a viral infection.
Introduction
The management of sore throat in general practice is
traditionally based on the doctor’s clinical judgment and
empirical treatment. However, as the rate of prescribing
remains quite high for a condition mostly due to viral
causes, distinguishing between non-bacterial and bacter-
ial causes of sore throat is still important [1].
Clinical scoring systems have been developed to help
recognise bacterial or non-bacterial sore throats, e.g.
Centor’s and Breese’s criteria, which are based on 4 and
9 items respectively, and which only use clinical vari-
ables (see Table 1). However, there are several short-
comings to existing systems such as limitations in their
sensitivity (Breese 68%; Centor 65% to 83%) and their
specificity (Breese 85%; Centor 67%-91%) [2]. An accu-
rate scorecard will remain valuable whenever alternative
techniques for identifying bacterial or non bacterial
causes, such as rapid antigen testing and throat swab
culture, are unaffordable, unavailable or impractical.
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card shows benefits over other ones published in the
medical literature. For example, the widely used Centor
scorecard has less than optimal sensitivity and specifi-
city. When tested in an urban emergency department
using the four criteria, throat culture was positive in
56% of these patients and in patients meeting three cri-
teria, the positive predictive value of a positive culture
was only 30% to 34% [3].
The new scorecard was developed from ten criteria
which included 4 from Centor (i.e. tonsilar exudates;
tender anterior cervical adenopathy; fever by history;
and absence of cough). One criterion was taken from
Breese’s study [4] (season of illness - late winter or early
spring), and one from Wald’s study [5] (age 5-15 years).
The four remaining criteria were selected by the inves-
tigator as they seemed relevant to sore throat and were
considered useful in increasing the accuracy of the scor-
ecard, based on the author’s experience. These criteria
included:
￿ History of exposure to group A streptococcal sore
throat infection [6].
￿ Purulent nasopharyngeal discharge associated with
sore throat [7].
￿ Duration of illness > 5 days; longer duration of
symptoms or illness may indicate a Strep A sore
throat [8].
￿ History of hoarseness or changes in voice - this
symptom has been associated with a high negative
predictive value [9,10].
T h ei n v e s t i g a t o rw a so ft h ev i e wt h a tb yi n c l u d i n g
additional clinical features to the 4 Centor’s criteria, the
accuracy of a scoring system could be improved. The
aim of this study was therefore to evaluate the validity
of a newly developed clinical scorecard in managing
sore throat and also to determine the acceptability of
this scorecard by patients and carers. While an instru-
ment may be successfully validated, it may not
necessarily appeal to the subjects for which it was
intended, in this case, the patients and carers. Hence,
the importance of also studying the acceptability of the
scorecard.
Methods
Setting
The study was conducted by the investigator, a solo
family physician working in Cobar, a rural town in New
South Wales, Australia, with a population of close to six
thousand people. The investigator worked full time in
his medical practice which was open for 9 -10 hours
daily, six days a week. There were on average 30 to 50
patients per day, with over two hundred per week. The
research took place at the investigator’s practice between
April and December 2006 following ethics committee
approval from Monash University.
Scorecard development
The Centor criteria have provided the most widely used
and accepted scorecard in America and in many other
countries. The proposed new scorecard of ten factors,
therefore, contains Centor’s four factors and six addi-
tional factors as explained in the previous section. The
final version of the scorecard is presented in Figure 1.
Questionnaire development
A patient/guardian perception questionnaire on sore
throat was developed for this study using a five point
Likert scale (5 Strongly agree, 4 Agree, 3 Neutral, 4 Dis-
agree and 1 Strongly disagree). This questionnaire
examined attitudes to and beliefs about the use of a
scorecard and also collected additional information such
as the severity of symptoms of the current sore throat.
Subject recruitment
Patients were made aware of the study via a poster
placed in the waiting room and at the reception area.
Patients from the age of 5 years and above presenting
predominantly with a sore throat and who had not had
Table 1 Comparison of new scorecard with other scoring systems used in diagnosing group A streptococcal (GAS)
pharyngitis
Study
author
(year)
Features included in final algorithm Age
group
(years)
Sample
size
Sensitivity
(%)
Specificity
(%)
Positive
predictive
value(%)
The
current
scorecard
Ten criteria (See Figure 1) 5 yrs to
99 yrs
106 93.3 63.2 50
Breese‡
(1977)15
Season (late winter or early spring) Age (5-10 years) Elevated white
blood cell count Temperature > 38°C Sore throat Absence of cough
Headache Pharyngeal erythema or oedema or exudates Tender or
enlarged cervical lymph nodes
Children 670 68 85 84
Centor†
(1981)16
History of fever Tonsillar exudates Tender and enlarged anterior
cervical lymph nodes Absence of cough
> 15 234 65-83 67-91 56
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sequentially invited to participate. If they or their guar-
dian agreed, one or the other then signed a consent
form.
Procedure
A throat swab was taken from all patients participating
in the sore throat study by rubbing vigorously against
each tonsil as recommended by Brien and Bass [11].
After taking the swab, the doctor completed a scorecard
for each patient participating in the study. Adult
patients (>16 yrs) were asked to complete a patient
questionnaire, while guardians accompanying children
(5 yr to <16 yrs old) were asked to complete a similar,
guardian questionnaire. Patients either completed the
questionnaire while still in the consulting room or in
the waiting room. This was then placed in a secure box
in the reception area or handed back to the doctor by
the receptionist.
Handling of throat swab
The throat swab was transported in an individually cov-
ered Stewart’s transport medium to the regional pathol-
ogy service in Dubbo, New South Wales, Australia, for
microscopy, culture and sensitivity. The throat swabs
were forwarded within 24 hours of collection.
Cultures showing any group A beta haemolytic Strep-
tococci, Streptococci groups B, C and G, and staphylo-
cocci were considered positive. Cultures showing mixed
respiratory flora, Candida and non-specific growths were
considered negative. Undertaking viral studies was not
feasible in this setting and so the absence of bacterial
growth was assumed to reflect a viral infection or other
minor causes such as allergy.
Data analysis
Patients were assigned to one of two groups based on
the results of the scorecard:
￿ Bacterial group A: patients who had a bacterial
score of ≥ 5 and a non-bacterial score of ≤ 4.
￿ Non-bacterial group B: patients with a non-bacter-
ial score of ≥ 6a n dab a c t e r i as c o r eo f≤ 4o nt h e
scorecard.
The data obtained from the scorecard, the throat swab
pathology reports from the laboratory and the question-
naires were checked and then tabulated using the
Microsoft Excel program. They were subjected to a
recheck and analysis by a statistician. The sensitivity,
specificity, predictive values and the accuracy of the
scorecard were determined by comparing the scorecard
findings with the gold standard of the throat swab. Data
from the completed patient and guardian questionnaires
were analysed using histograms to plot the frequencies
of responses to the questionnaire against the 5 Likert
scale responses. The Pearson’s product moment test was
used to confirm that the correlation between the score-
card and the throat swab results were within an accepta-
ble range. The analysis was repeated using the
non-parametric Spearman’sr h ot e s t .C r o n b a c h ’sa l p h a
was used to verify that the internal consistency of the
guardian and adult questionnaires was within an accep-
table range.
Results
Subject participation
Over a thousand patients were seen between April and
December 2006, out of which one hundred and eighteen
patients presented with sore throat. All of these were
approached to enter the study, but 12 patients were
excluded either because they had refused a throat swab
or refused to complete a questionnaire.
Participants in the study included twenty-four children
under the age of 16 years who were accompanied by par-
ents or guardians (22 mothers, 1 father and 1 grand-
mother), with fourteen of the children being male and
with a mean age was 8.71 years (standard deviation 3.76,
range 5 to <16 yrs). There were 82 adult patients, with 30
of them being male. The mean age in the adult group
was 34.85 (standard deviation 15.25, range 15 to 81).
Child group
In the child group, 7 patients had a true positive result for
bacterial infection (i.e. scorecard and microbiological cul-
ture in agreement) and none had a false negative result, i.
e. a sensitivity or true positive rate of 7/7, or 100% (Table
2). Further, 9 patients had a false positive result for non-
bacterial infection (positive on scorecard and negative on
microbiological culture) and 8 patients had a true negative
(negative on scorecard and negative microbiological cul-
ture). This means that the specificity of the scorecard for
the child group was 8/17 or 47.1%, giving an accuracy for
the child group which is also 47.1%.
Adult group
In the adult group, 21 patients had a true positive result
for bacterial infection, while 2 had a false negative
Table 2 Aetiology of sore throat: child group
Swab Number of patients
Score Card Bacterial Non-bacterial
Positive 7 9 16
(True Positive) (False Positive)
Negative 0 8 8
(False Negative) (True Negative)
N 7 17 24
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culture) result (See Table 3). This gives a true positive
rate or sensitivity for bacterial infection in the adult
group of 21/23 or 91.3%. Similarly, 19 patients had a
false positive result for non-bacterial infection while 40
patients had a true negative result. This means that the
specificity for the adult group equalled 40/59 or 67.8%.
The accuracy of the scorecard for the adult group was
therefore 91.3% × 67.8% or 61.9%.
Streptococcal group A was only identified in 11/106 or
10% of the patients with sore throat (Table 4). The scor-
ecard’s positive predictive value for bacterial sore throat
was 50% in both adult and child groups and the negative
predictive value was 96% in both groups. The sensitivity
in the adult group was 91.3% as compared with 100%
sensitivity in the child group, with an overall sensitivity
of 93.3%. The specificity in the adult group was 67.8%
as compared with a specificity of 47.1% in the child
group, and with an overall specificity of 63.2%. The
accuracy of the scorecard was 58.9%. Patient of age less
than 16 years was the only criterion out of the ten in
the scorecard that emerged as an independent predictor
of sore throat streptococcal infection. The combined
group bacterial and non-bacterial positive and negative
ratios are listed in (Table 5).
A total of 94.3% of patients agreed that they would
r e l yo nt h e i rd o c t o rt od e c i d ew h e t h e ro rn o tt h e y
needed an antibiotic. If there was a reliable scorecard,
85.8% of patients would trust such a scorecard.
Validation of the scorecard
The Pearson product-moment correlation between the
scorecard and the throat swab for the guardian group
was -0.454 (significant at the .05 level), and for the adult
group was -0.531 (significant at the .01 level). In general,
correlation coefficients of at least 0.7 are considered
‘strong’, although the above results are acceptable.
Cronbach’s alpha for the guardian (i.e. child) group
was 0.685 and for the adult group was 0.670, and these
are acceptable values for internal reliability.
Discussion
The sensitivity of the scorecard was 93.3% and the spe-
cificity was 63.2%, giving an accuracy of 58.9%. This
means that the scorecard gave a reliable answer in just
over half (i.e. 58.9%) of patients who presented with a
sore throat. Most other scoring systems have either a
lower or at least no better accuracy. Although more sen-
sitive, the new scorecard has a lower specificity (63.2%)
than other scoring systems, e.g. Breese (85%) and Centor
(67%-91%) [2]. The new scorecard is therefore, with a
sensitivity of 93.3%, more likely to confirm a bacterial
sore throat than other previous scorecards, but a little
less likely to identify a ‘true negative’, which is a viral
sore throat. The implication of this in clinical practice is
that doctors may be more confident when the scorecard
indicates a viral sore throat, but when it predicts a bac-
terial sore throat, given that the scorecard has a low
specificity, (i.e. a high false positive rate) we cannot be
absolutely confident that it is bacterial. Follow up of the
patient may be required to ensure that the sore throat
resolves as would be expected for a viral cause, and if it
does not, it should be treated as bacterial.
Apart from age less than 16 years, none of the other
ten criteria in the scorecard emerged as an independent
predictor of bacterial infection for sore throat.
There are several limitations to this study. First, the cur-
rent study was conducted by only one investigator with a
fairly small number of subjects (106). Hence further stu-
dies may be necessary to confirm the findings. Compar-
able studies had higher numbers of subjects, for example,
there were 234 in Centor’s study [12], 670 in Breese’s [4],
513 in McIsaac’s [13] and 418 in Walsh’s [14].
Table 3 Aetiology of sore throat: adult group
Swab N
Score Card Bacterial Viral
Positive 21 19 40
(True Positive) (False Positive)
Negative 2 40 42
(False Negative) (True Negative)
N2 3 5 9 8 2
Table 4 Aetiology of sore throat by group
Children Adult TOTAL
Aetiology Male Female Male Female
Normal throat flora 11 6 19 40 76
Strep A 22341 1
Strep B 0110 2
Strep C 0135 9
Strep G 0022 4
Strep pyogenes 0001 1
Staph aureus 1020 3
Total number of subjects 14 10 30 52 106
Table 5 Aetiology of sore throat for all subjects
(combined)
Swab Number of patients
Score Card Bacterial Non-bacterial
Positive 28 28 56
(True Positive) (False Positive)
Negative 2 48 50
(False Negative) (True Negative)
N 30 76 106
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mine how many patients with sore throat are required
to develop a more accurate scorecard than existing
ones. In that sense, this study must be considered to be
a pilot study.
Other researchers have used only bacterial throat swab
cultures to investigate sore throats and have not done
viral cultures on pragmatic grounds [15,16]. The diagno-
sis of viral infection is therefore presumptive. The same
applies to this study.
The original wording of two of the items in the score-
card could have been clearer. Questions 7 and 10 were
stated negatively and were therefore reverse scored in
the analysis. They could have been positively stated in
the first place and then reversely scored if necessary.
Further, there were limitations with criterion 4 which
referred to a history of exposure to a person with bac-
terial sore throat infection (e.g. GAS, Group C, Strep
pyogenes). It is of course hard to prove the cause of a
sore throat from the taking of a history. This criterion
was often scored as a “No” in doubtful cases (i.e. non-
bacterial). This might have skewed the overall scorecard
result toward the non-bacterial causes, but the extent of
such an effect is unknown. It should be noted that the
scorecard cannot differentiate between Streptococcal
groups A, B, C or G based on clinical presentation.
The usefulness in patients under 5 years of age is
unknown as they were excluded from the study, given
that it would have been too difficult to take throat
swabs from them.
Although patient trust in the use of the scorecard is
high, there is some evidence that where laboratory tests
are available and practical, such as the rapid antigen
test, patient trust in their doctor’sj u d g e m e n t ,w i t ho r
without a scorecard, is diminished [17]. However, as the
use of these tests remains severely limited, clinical scor-
ecards such as the new one can be helpful as a practical
tool for decision making in general practice.
Conclusions
The sore throat scorecard presented in the current
study appears to be more sensitive than several others
published in the literature. However, its specificity is a
little less. While all the other scoring systems focused
on Streptococcal group A infection only, the new score-
card also included other bacterial organisms as
pathogens.
The scorecard could predict non-bacterial sore throat
in 96% of cases when the bacterial score was less than
or equal to four (i.e. its negative predictive value). How-
ever, the positive predictive value of the scorecard was
50%, meaning that the scorecard could predict bacterial
sore throat infection in about 50% of the cases when the
bacterial score was greater than or equal to five.
Ideally, the scorecard would be both sensitive and
specific. However, given that the problem with antibio-
tic use in general practice tends to be overuse, it
would be preferable if the scorecard identified few
false positives. Unfortunately, given the relatively low
specificity, “positive” results may give more false posi-
tives than ideal. On the other hand, a “negative” result
is clinically significant in that it tends to rule out
bacterial sore throat because the new scorecard has a
sufficiently high sensitivity (93.3%), i.e. low false nega-
tives. In summary, the scorecard is most useful when
the result is negative.
Further research is required to study the attitudes of
doctors to the scorecard at the point of care. However,
trust by patients was high.
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